China Jo-Jo Drugstores Granted Extension to Meet Nasdaq Minimum Bid Price Requirement
China Jo-Jo Drugstores (NASDAQ: CJJD) received a 180-day extension from Nasdaq to meet the $1.00 minimum bid price requirement, now until July 25, 2022. The company must close at or above this price for 10 consecutive trading days to regain compliance. This follows a prior notification on July 26, 2021, about failing to maintain the required minimum bid price over 30 trading days.
- Received a 180-day extension from Nasdaq to meet minimum bid price requirement.
- Has until July 25, 2022, to regain compliance with Nasdaq listing rules.
- Previously notified on July 26, 2021, for failing to maintain the minimum bid price.
HANGZHOU, China, Jan. 26, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on January 25, 2022, the Company received another 180 calendar day extension from Nasdaq's Listing Qualifications Department to meet Nasdaq's continuing listing requirements by maintaining a minimum bid price per share of
If at any time before July 25, 2022, the bid price of the Company's ordinary shares closes at or above
The Company was first notified by Nasdaq of its failure to maintain a minimum bid price of
About China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com. The Company routinely posts important information on its website.
Forward-Looking Statements
This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.
For more information, please contact:
Company Contact:
Frank Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
View original content:https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-granted-extension-to-meet-nasdaq-minimum-bid-price-requirement-301468212.html
SOURCE China Jo-Jo Drugstores, Inc.
FAQ
What is the current status of CJJD's Nasdaq listing compliance?
When was the last notification received regarding CJJD's stock price?
What must CJJD do to regain compliance with Nasdaq?
